Added to YB: 2025-10-03
Pitch date: 2025-10-01
CLPT [bullish]
ClearPoint Neuro, Inc.
-55.59%
current return
Author Info
MVC Investing is a long-term investor. BSc in Economics, MSc in Finance. Equity Analyst with a focus on Fundamental Analysis and Valuation. Sign up for the newsletter.
Company Info
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States.
Market Cap
$272.3M
Pitch Price
$21.12
Price Target
N/A
Dividend
N/A
EV/EBITDA
-14.10
P/E
-10.18
EV/Sales
7.70
Sector
Health Care Equipment and Supplies
Category
growth
M. V. Cunha | Portfolio Update – 09/30/2025 – Q3 Review: Added - ClearPoint Neuro, Inc.
CLPT added position: AMT-130 data validates platform as enabling infrastructure for CNS therapies - first visible proof concept works. Stock +58.5% on 29x volume. 60+ partnered programs, shift from speculative to validated platform. $600M market cap still values as niche medtech vs platform potential.
Read full article (2 min)